Emory University: Anemia, Sickle Cell trials

The registry lists 28 Anemia, Sickle Cell studies with Emory University as lead sponsor. 4 are open to participants now and 9 have results posted.

Early Phase 1 2Phase 1 4Phase 2 6Phase 4 1No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencingRecruitingNCT07562451Not applicable
• Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell DiseaseRecruitingNCT07090668Not applicable
• Integrative Training Program for Pediatric Sickle Cell PainRecruitingNCT06691867Not applicable
• Arginine Therapy for the Treatment of Pain in Children With Sickle Cell DiseaseRecruitingNCT02447874Phase 1/2
• Development and Adaptation of I-STRONG for SCDCompletedNCT06110754Not applicableResults posted
• Home-Based Intervention for Chronic Pain in Adults With Sickle Cell DiseaseCompletedNCT04906707Not applicableResults posted
• Building Adaptive Coping and Knowledge to Improve Daily LifeCompletedNCT04602728Not applicableResults posted
• Acceptability, Feasibility and Safety of a Yoga Program for Chronic Pain in Sickle Cell DiseaseTerminatedNCT03694548Not applicableResults posted
• Transplantation for Patients With Sickle Cell Disease From Mismatched Family Donors of Bone MarrowCompletedNCT02757885Phase 2Results posted
• Arginine Therapy for Sickle Cell Disease PainCompletedNCT02536170Phase 2Results posted
• Decision Aid for Therapeutic Options In Sickle Cell DiseaseCompletedNCT02326597Not applicableResults posted
• Bone Marrow Transplantation in Young Adults With Severe Sickle Cell DiseaseCompletedNCT01565616Phase 2Results posted
• Alefacept and Allogeneic Hematopoietic Stem Cell TransplantationTerminatedNCT01319851Not applicableResults posted
• Prophylactic Transfusion In Pregnant in Women With Sickle Cell DiseaseWithdrawnNCT06979492Phase 4
• Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell TransplantationActive, not recruitingNCT04018937Phase 2
• Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant TransplantActive, not recruitingNCT03924401Phase 2
• Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell DiseaseTerminatedNCT03577691Not applicable
• Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell DiseaseWithdrawnNCT03298399Phase 1
• Sickle Cell Disease (SCD) Decision AidCompletedNCT03224429Not applicable
• STRIDE BiorepositoryStatus unknownNCT02843347
• Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell DiseaseCompletedNCT02371720Not applicable
• Losartan for Sickle Cell Kidney DiseaseCompletedNCT01989078Early Phase 1
• Bone Marrow Transplant With Abatacept for Non-Malignant DiseasesCompletedNCT01917708Phase 1
• Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell DiseaseCompletedNCT01369160
• Sickle Cell Disease Conditioning for Bone Marrow TransplantCompletedNCT00968162Phase 1
• Kidney Transplantation in Patients With Sickle Cell DiseaseTerminatedNCT00663507
• SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell DiseaseTerminatedNCT00257543Early Phase 1
• Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCDCompletedNCT00228631